UT Health San Antonio develops drug found to more than double survival time for glioblastoma patients

New hope for adult sufferers of most common primary brain tumor Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, March 7, 2025 – A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary […]